Published in J Neurosci on September 20, 2006
Schwann cell phenotype is regulated by axon modality and central-peripheral location, and persists in vitro. Exp Neurol (2013) 1.62
Functional Role of the Disulfide Isomerase ERp57 in Axonal Regeneration. PLoS One (2015) 1.55
The lh3 Glycosyltransferase Directs Target-Selective Peripheral Nerve Regeneration. Neuron (2015) 1.40
Designing ideal conduits for peripheral nerve repair. Neurosurg Focus (2009) 1.38
The design of electrospun PLLA nanofiber scaffolds compatible with serum-free growth of primary motor and sensory neurons. Acta Biomater (2008) 1.36
Sensitization of cutaneous nociceptors after nerve transection and regeneration: possible role of target-derived neurotrophic factor signaling. J Neurosci (2009) 1.32
Accelerating axonal growth promotes motor recovery after peripheral nerve injury in mice. J Clin Invest (2011) 1.31
Schwann cells: activated peripheral glia and their role in neuropathic pain. Brain Behav Immun (2007) 1.27
Immortalization and characterization of a nociceptive dorsal root ganglion sensory neuronal line. J Peripher Nerv Syst (2007) 1.16
Limited regeneration in long acellular nerve allografts is associated with increased Schwann cell senescence. Exp Neurol (2013) 1.00
Long-term changes in neurotrophic factor expression in distal nerve stump following denervation and reinnervation with motor or sensory nerve. J Neurochem (2008) 0.99
Neurobiology of peripheral nerve injury, regeneration, and functional recovery: from bench top research to bedside application. Ochsner J (2013) 0.98
Schwann cell influence on motor neuron regeneration accuracy. Neuroscience (2009) 0.97
Differential gene expression in motor and sensory Schwann cells in the rat femoral nerve. J Neurosci Res (2011) 0.95
Introduction to special issue: Challenges and opportunities for regeneration in the peripheral nervous system. Exp Neurol (2009) 0.95
3D Printed Anatomical Nerve Regeneration Pathways. Adv Funct Mater (2015) 0.94
c-Jun activation in Schwann cells protects against loss of sensory axons in inherited neuropathy. Brain (2014) 0.92
Electrical Stimulation to Enhance Axon Regeneration After Peripheral Nerve Injuries in Animal Models and Humans. Neurotherapeutics (2016) 0.90
An in vitro model of adult mammalian nerve repair. Exp Neurol (2009) 0.90
Altered cutaneous nerve regeneration in a simian immunodeficiency virus / macaque intracutaneous axotomy model. J Comp Neurol (2009) 0.90
Schwann cells seeded in acellular nerve grafts improve functional recovery. Muscle Nerve (2013) 0.89
The role of oxidative stress in nervous system aging. PLoS One (2013) 0.89
Matching of motor-sensory modality in the rodent femoral nerve model shows no enhanced effect on peripheral nerve regeneration. Exp Neurol (2010) 0.88
Sensory axon targeting is increased by NGF gene therapy within the lesioned adult femoral nerve. Exp Neurol (2009) 0.88
Novel roles for osteopontin and clusterin in peripheral motor and sensory axon regeneration. J Neurosci (2014) 0.87
Strategies to promote peripheral nerve regeneration: electrical stimulation and/or exercise. Eur J Neurosci (2015) 0.87
The impact of motor and sensory nerve architecture on nerve regeneration. Exp Neurol (2008) 0.87
Peripheral nerve injury: principles for repair and regeneration. Open Orthop J (2014) 0.86
Electrical stimulation of schwann cells promotes sustained increases in neurite outgrowth. Tissue Eng Part A (2013) 0.85
Pathways regulating modality-specific axonal regeneration in peripheral nerve. Exp Neurol (2015) 0.85
Immunohistochemical, ultrastructural and functional analysis of axonal regeneration through peripheral nerve grafts containing Schwann cells expressing BDNF, CNTF or NT3. PLoS One (2013) 0.85
Functional recovery of denervated skeletal muscle with sensory or mixed nerve protection: a pilot study. PLoS One (2013) 0.84
Neural cell type-specific responses to glycomimetic functionalized collagen. Biomaterials (2011) 0.83
The differential effects of pathway- versus target-derived glial cell line-derived neurotrophic factor on peripheral nerve regeneration. J Neurosurg (2010) 0.83
Early changes of beta-Catenins and Menins in spinal cord dorsal horn after peripheral nerve injury. Cell Mol Neurobiol (2010) 0.83
Modification of Schwann cell gene expression by electroporation in vivo. J Neurosci Methods (2008) 0.82
Expression of NGF and GDNF family members and their receptors during peripheral nerve development and differentiation of Schwann cells in vitro. Neurosci Lett (2009) 0.82
Nerve cross-bridging to enhance nerve regeneration in a rat model of delayed nerve repair. PLoS One (2015) 0.82
A novel model for evaluating nerve regeneration in the composite tissue transplant: the murine heterotopic limb transplant. Hand (N Y) (2011) 0.81
A guidance channel seeded with autologous Schwann cells for repair of cauda equina injury in a primate model. J Spinal Cord Med (2009) 0.81
Glial cell line-derived neurotrophic factor promotes increased phenotypic marker expression in femoral sensory and motor-derived Schwann cell cultures. Exp Neurol (2014) 0.80
Ventral root re-implantation is better than peripheral nerve transplantation for motoneuron survival and regeneration after spinal root avulsion injury. BMC Surg (2013) 0.80
Pleiotrophin and peripheral nerve injury. Neurosurg Rev (2009) 0.80
Neuromuscular Regeneration: Perspective on the Application of Mesenchymal Stem Cells and Their Secretion Products. Stem Cells Int (2016) 0.80
Gene expression of axon growth promoting factors in the deer antler. PLoS One (2010) 0.79
Adult motor axons preferentially reinnervate predegenerated muscle nerve. Exp Neurol (2013) 0.78
Delayed peripheral nerve repair: methods, including surgical 'cross-bridging' to promote nerve regeneration. Neural Regen Res (2015) 0.78
GDNF preconditioning can overcome Schwann cell phenotypic memory. Exp Neurol (2014) 0.78
Long-term effects of a lumbosacral ventral root avulsion injury on axotomized motor neurons and avulsed ventral roots in a non-human primate model of cauda equina injury. Neuroscience (2013) 0.78
Spatiotemporal expression profiling of proteins in rat sciatic nerve regeneration using reverse phase protein arrays. Proteome Sci (2012) 0.78
Combination of microsurgery and gene therapy for spinal dorsal root injury repair. Mol Ther (2009) 0.78
Reimplantation of avulsed lumbosacral ventral roots in the rat ameliorates injury-induced degeneration of primary afferent axon collaterals in the spinal dorsal columns. Neuroscience (2007) 0.78
Treadmill exercise facilitates recovery of locomotor function through axonal regeneration following spinal cord injury in rats. J Exerc Rehabil (2016) 0.78
Polysialic acid expression is not necessary for motor neuron target selectivity. Muscle Nerve (2012) 0.77
Cellular therapies for treating pain associated with spinal cord injury. J Transl Med (2012) 0.76
Neurotrophin treatment to promote regeneration after traumatic CNS injury. Front Biol (Beijing) (2013) 0.76
Schwann cells - a new hope in tissue engineered urinary bladder innervation. A method of cell isolation. Cent European J Urol (2011) 0.76
Accuracy of regenerating motor neurons: influence of diffusion in denervated nerve. Neuroscience (2014) 0.76
Geometrical versus Random β-TCP Scaffolds: Exploring the Effects on Schwann Cell Growth and Behavior. PLoS One (2015) 0.76
Transcriptome Analysis of Chemically-Induced Sensory Neuron Ablation in Zebrafish. PLoS One (2016) 0.76
The use of brief post-surgical low frequency electrical stimulation to enhance nerve regeneration in clinical practice. J Physiol (2016) 0.76
Modulation of the visceromotor reflex by a lumbosacral ventral root avulsion injury and repair in rats. Am J Physiol Renal Physiol (2012) 0.76
Dose-Dependent Differential Effect of Neurotrophic Factors on In Vitro and In Vivo Regeneration of Motor and Sensory Neurons. Neural Plast (2016) 0.76
Preferential Enhancement of Sensory and Motor Axon Regeneration by Combining Extracellular Matrix Components with Neurotrophic Factors. Int J Mol Sci (2016) 0.75
Femoral nerve regeneration and its accuracy under different injury mechanisms. Neural Regen Res (2015) 0.75
Protein expression of sensory and motor nerves: Two-dimensional gel electrophoresis and mass spectrometry. Neural Regen Res (2012) 0.75
Expression changes of nerve cell adhesion molecules L1 and semaphorin 3A after peripheral nerve injury. Neural Regen Res (2016) 0.75
Combined use of Y-tube conduits with human umbilical cord stem cells for repairing nerve bifurcation defects. Neural Regen Res (2016) 0.75
Promoting peripheral myelin repair. Exp Neurol (2016) 0.75
Nerve regeneration in the peripheral and central nervous systems. J Physiol (2016) 0.75
Predegenerated Schwann cells-a novel prospect for cell therapy for glaucoma: neuroprotection, neuroregeneration and neuroplasticity. Sci Rep (2016) 0.75
Selectivity in the reinnervation of the lateral gastrocnemius muscle after nerve repair with ethyl cyanoacrylate in the rat. Front Neurol (2011) 0.75
A two-compartment organotypic model of mammalian peripheral nerve repair. J Neurosci Methods (2014) 0.75
Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons. Exp Neurol (2016) 0.75
Repair, protection and regeneration of peripheral nerve injury. Neural Regen Res (2015) 0.75
Motor neuron target selectivity and survival after prolonged axotomy. Restor Neurol Neurosci (2013) 0.75
Structural and Functional Substitution of Deleted Primary Sensory Neurons by New Growth from Intrinsic Spinal Cord Nerve Cells: An Alternative Concept in Reconstruction of Spinal Cord Circuits. Front Neurol (2017) 0.75
Cauda equina repair in the rat: Part 3. Axonal regeneration across Schwann cell seeded collagen foam. Muscle Nerve (2017) 0.75
Covalent binding of placental derived proteins to silk fibroin improves schwann cell adhesion and proliferation. J Mater Sci Mater Med (2016) 0.75
Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology (2007) 8.08
Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science (2001) 4.82
The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology (2003) 3.60
Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch Neurol (1998) 3.39
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol (1992) 2.52
Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons. J Neurosci (1998) 2.43
Brief electrical stimulation promotes the speed and accuracy of motor axonal regeneration. J Neurosci (2000) 2.43
Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease. Cell (1993) 2.40
Neurofilament gene expression: a major determinant of axonal caliber. Proc Natl Acad Sci U S A (1987) 2.36
Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology (2007) 2.32
Multifocal motor neuropathy: response to human immune globulin. Ann Neurol (1993) 2.32
Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol (1993) 2.23
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects. Neurology (1977) 2.19
Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection. Neurology (1997) 2.15
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol (1988) 2.12
Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol (1993) 2.09
Blindness after reduction of facial fractures. Plast Reconstr Surg (1998) 2.08
Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol (1987) 2.05
Control of axonal caliber by neurofilament transport. J Cell Biol (1984) 2.03
Slow axonal transport of neurofilament proteins: impairment of beta,beta'-iminodipropionitrile administration. Science (1978) 2.00
Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A (1999) 1.95
Cutaneous innervation in sensory neuropathies: evaluation by skin biopsy. Neurology (1995) 1.95
Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology (1999) 1.93
Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J Neurosci (1995) 1.88
The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization. RNA (1997) 1.84
Three-dimensional optical coherence tomography of Barrett's esophagus and buried glands beneath neosquamous epithelium following radiofrequency ablation. Endoscopy (2009) 1.82
Closure of chronic abdominal wall defects: a long-term evaluation of the components separation method. Ann Plast Surg (1999) 1.81
Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene (2012) 1.80
Neurovascular protection reduces early brain injury after subarachnoid hemorrhage. Stroke (2004) 1.79
Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradation. J Neurocytol (1989) 1.79
Early onset of spontaneous activity in uninjured C-fiber nociceptors after injury to neighboring nerve fibers. J Neurosci (2001) 1.66
Bedside end-tidal CO2 tension as a screening tool to exclude pulmonary embolism. Eur Respir J (2009) 1.63
Schwann cell phenotype is regulated by axon modality and central-peripheral location, and persists in vitro. Exp Neurol (2013) 1.62
Electrical stimulation accelerates and increases expression of BDNF and trkB mRNA in regenerating rat femoral motoneurons. Eur J Neurosci (2000) 1.60
Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol (1988) 1.60
Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology (1993) 1.59
Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol (1996) 1.59
Changes in neurofilament transport coincide temporally with alterations in the caliber of axons in regenerating motor fibers. J Cell Biol (1985) 1.55
Using bulked extremes and recessive class to map genes for photoperiod-sensitive genic male sterility in rice. Proc Natl Acad Sci U S A (1994) 1.55
Prolonged survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic of the axon. J Neurocytol (1993) 1.54
Pathogenesis of Borna disease in rats: evidence that intra-axonal spread is the major route for virus dissemination and the determinant for disease incubation. J Virol (1987) 1.53
Regional modulation of neurofilament organization by myelination in normal axons. J Neurosci (1994) 1.49
Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study. Environ Health Perspect (1998) 1.46
Sensory nerve pathology in multifocal motor neuropathy. Ann Neurol (1996) 1.46
Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology (2000) 1.45
Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients. Neurology (2006) 1.45
HIV neuropathy: insights in the pathology of HIV peripheral nerve disease. J Peripher Nerv Syst (2001) 1.45
Physiologic-pathologic correlation in Guillain-Barré syndrome in children. Neurology (2000) 1.43
The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy. Neurology (2006) 1.42
Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis (2001) 1.40
Subunit composition of neurofilaments specifies axonal diameter. J Cell Biol (1996) 1.39
Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol (1998) 1.39
Halotolerance of Methanobacterium thermoautotrophicum delta H and Marburg. J Bacteriol (1994) 1.39
Segregation analysis of esophageal cancer in a moderately high-incidence area of northern China. Am J Hum Genet (2000) 1.37
Co-localization of the myelin-associated glycoprotein and the microfilament components, F-actin and spectrin, in Schwann cells of myelinated nerve fibres. J Neurocytol (1989) 1.37
Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes. J Virol (1993) 1.36
Delayed macrophage responses and myelin clearance during Wallerian degeneration in the central nervous system: the dorsal radiculotomy model. Exp Neurol (1994) 1.36
Erlotinib as second-line treatment in patients with advanced non-small-cell lung cancer and asymptomatic brain metastases: a phase II study (CTONG-0803). Ann Oncol (2012) 1.36
High-affinity anti-ganglioside IgG antibodies raised in complex ganglioside knockout mice: reexamination of GD1a immunolocalization. J Neurochem (2000) 1.34
Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol (1988) 1.34
Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol (1996) 1.34
Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain (2002) 1.34
Complications of endoscopic injection sclerotherapy: a review. Am J Gastroenterol (1987) 1.33
Arf family GTPases: roles in membrane traffic and microtubule dynamics. Biochem Soc Trans (2005) 1.33
Long-term physical impairment and functional outcomes after complex facial fractures. Plast Reconstr Surg (2001) 1.33
Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30
The axonal pathology in chronic IDPN intoxication. J Neuropathol Exp Neurol (1980) 1.30
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol (1999) 1.28
Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology (1997) 1.27
Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis. J Neuroimmunol (2008) 1.26
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. II. General pathologic, neuropathologic, and biochemical aspects. Neurology (1977) 1.26
Increasing neurofilament subunit NF-M expression reduces axonal NF-H, inhibits radial growth, and results in neurofilamentous accumulation in motor neurons. J Cell Biol (1995) 1.25
Effect of muscle disuse on acetylcholine receptors. Nature (1976) 1.25
Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22
SPO14 separation-of-function mutations define unique roles for phospholipase D in secretion and cellular differentiation in Saccharomyces cerevisiae. Genetics (2001) 1.22
Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines. Adv Med Sci (2011) 1.21
Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies. Ann Neurol (1990) 1.21
Measurement and correlates of ano-genital distance in healthy, newborn infants. Int J Androl (2010) 1.21
A diallel analysis of heterosis in elite hybrid rice based on RFLPs and microsatellites. Theor Appl Genet (1994) 1.21
Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency. Br J Cancer (1990) 1.20
Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry. J Neuroimmunol (1997) 1.20
Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am J Hum Genet (1998) 1.19
Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.19
Lymphomatous leptomeningitis. Am J Med (1971) 1.18
Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy. Diabetes Technol Ther (2001) 1.17
Effects of aging on nerve sprouting and regeneration. Exp Neurol (1980) 1.17
ROS1 fusions in Chinese patients with non-small-cell lung cancer. Ann Oncol (2013) 1.17
Epidermal innervation: changes with aging, topographic location, and in sensory neuropathy. J Neurol Sci (1999) 1.16
Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility. Neurology (1998) 1.14
Motor conduction studies in Guillain-Barré syndrome: description and prognostic value. Ann Neurol (1988) 1.13
Alteration in connections between muscle and anterior horn motoneurons after peripheral nerve repair. Science (1980) 1.13
Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology (2001) 1.12
Prospective evaluation of somatic and autonomic small fibers in selected autonomic neuropathies. Neurology (2004) 1.12